What is the current Fully Automatic Five-part Blood Cell Analyzer market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Fully Automatic Five-part Blood Cell Analyzer market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Fully Automatic Five-part Blood Cell Analyzer market?

Increasing demand for automated diagnostic systems and technological advancements drive the market.

What are the major challenges facing the Fully Automatic Five-part Blood Cell Analyzer market?

High equipment costs and maintenance requirements are significant challenges.

Which regions are the leaders in the Fully Automatic Five-part Blood Cell Analyzer market?

North America and Europe are the leading regions due to advanced healthcare infrastructure.

Who are the top companies in the Fully Automatic Five-part Blood Cell Analyzer market?

Leading companies include Beckman Coulter, Siemens, and Abbott Laboratories.

What future opportunities exist in the Fully Automatic Five-part Blood Cell Analyzer market?

Emerging markets and point-of-care diagnostics offer significant future opportunities.

What is the current regulatory landscape for the Fully Automatic Five-part Blood Cell Analyzer market?

Stringent regulations and standards govern the market, ensuring safety and efficacy.

How will the Fully Automatic Five-part Blood Cell Analyzer market size evolve in the next 5 years?

The market is expected to reach USD 1.8 billion by 2028, driven by increasing adoption.

Which Companies Lead the Fully Automatic Five-part Blood Cell Analyzer Market in 2026?

Fully Automatic Five-part Blood Cell Analyzer by Application (Hospital, Laboratory), by Types (Human Use, Veterinary Use), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 138

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 138

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Fully Automatic Five-part Blood Cell Analyzer Market Size | CAGR 10.2 Forecast 2033

Which Companies Lead the Fully Automatic Five-part Blood Cell Analyzer Market in 2026?

🏭 Healthcare🌍 Global

Pages: 138

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 138

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Fully Automatic Five-part Blood Cell Analyzer Market Overview

The Fully Automatic Five-part Blood Cell Analyzer market refers to the industry that specializes in the development and manufacturing of automated analyzers for blood cell counting and analysis. As a critical component of healthcare diagnostics, the Fully Automatic Five-part Blood Cell Analyzer market size is estimated to be around $1.3 billion in 2025. The growth outlook for this market is promising, with a market forecast that indicates a Compound Annual Growth Rate (CAGR) of 8.5% during the forecast period of 2026-2033. The industry expansion is driven by factors such as increasing demand for automated diagnostics, advancements in technology, and the need for accurate and efficient blood cell analysis. The scope of this market encompasses various types of analyzers, including laboratory-based and point-of-care devices, and caters to different end-users, such as hospitals, clinics, and research institutions.

Loading chart…

The growth of the Fully Automatic Five-part Blood Cell Analyzer market is influenced by key forces such as technological advancements, regulatory requirements, and changing consumer behavior. The largest region for this market is North America, while the fastest-growing region is Asia-Pacific, driven by increasing healthcare expenditure and demand for advanced diagnostics. The market is expected to witness significant growth due to the rising prevalence of blood disorders and the need for accurate and efficient blood cell analysis. As the market continues to evolve, it is essential for industry players to stay ahead of the curve and adapt to the changing landscape, driven by technological innovations, regulatory compliance, and shifting consumer needs.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.61 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Sysmex; Beckman Coulter; ABBOTT LABORATORIES; Siemens Healthcare Diagnostics Inc; Roche; HORIBA ABX SAS; Boule Diagnostics; Mindray; Biotech; Chengdu Seamaty Technology; Danaher Corporation; Nihon Kohden; Bio-Rad Laboratories; BioSystems; Diatron; Drew Scientific; EKF Diagnostics; Ortho Clinical Diagnostics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Fully Automatic Five-part Blood Cell Analyzer market is poised for significant growth, driven by various factors that are shaping its dynamics. Understanding these market dynamics is crucial for stakeholders to navigate the industry effectively.

Growth Drivers2 items

Advancements in technology have led to the development of more sophisticated and accurate Fully Automatic Five-part Blood Cell Analyzers, which is a key driver of the Fully Automatic Five-part Blood Cell Analyzer market size and its growth forecast.

Increasing demand for automated diagnostic solutions in clinical settings is also fueling the growth of the Fully Automatic Five-part Blood Cell Analyzer market, as these analyzers offer rapid and reliable test results, enhancing patient care and outcomes.

Restraints2 items

High costs associated with the purchase and maintenance of Fully Automatic Five-part Blood Cell Analyzers can be a significant restraint to their adoption, especially in resource-constrained healthcare facilities, potentially hindering the Fully Automatic Five-part Blood Cell Analyzer market size.

Stringent regulatory requirements and the need for compliance with various standards can also limit the growth of the Fully Automatic Five-part Blood Cell Analyzer market, as manufacturers must invest in research and development to ensure their products meet these requirements.

Opportunities2 items

Emerging markets present significant opportunities for the Fully Automatic Five-part Blood Cell Analyzer market, as these regions are witnessing an increase in healthcare expenditure and a growing demand for advanced diagnostic technologies, contributing to a positive growth forecast.

The integration of Fully Automatic Five-part Blood Cell Analyzers with other diagnostic systems and the development of point-of-care testing solutions offer opportunities for market expansion and innovation, further driving the Fully Automatic Five-part Blood Cell Analyzer market size.

Challenges2 items

Ensuring the accuracy and reliability of Fully Automatic Five-part Blood Cell Analyzers is a significant challenge, as any errors in test results can have serious implications for patient care, necessitating rigorous quality control measures and impacting the Fully Automatic Five-part Blood Cell Analyzer market.

Managing the supply chain and maintaining a stable inventory of reagents and consumables for these analyzers can also be challenging, particularly in regions with underdeveloped logistics and distribution networks, affecting the growth forecast of the Fully Automatic Five-part Blood Cell Analyzer market.

Market Segmentation

Loading chart…

The Application segment of the Fully Automatic Five-part Blood Cell Analyzer market refers to the various uses of these analyzers in different medical settings. This segment includes clinical laboratories, hospitals, and research institutions. Each of these sub-segments contributes to the overall market size, with clinical laboratories being the largest contributor due to the high volume of blood tests conducted in these settings. The Fully Automatic Five-part Blood Cell Analyzer segmentation by application is crucial in understanding the market dynamics and trends.

The Types segment of the Fully Automatic Five-part Blood Cell Analyzer market includes different subtypes of analyzers, such as [object Object] and [object Object]. These subtypes vary in terms of their features, functionality, and price points. Understanding the market taxonomy of these subtypes is essential in determining the overall market size and growth prospects. The types segment is further divided into sub-segments based on the level of automation, sample handling capacity, and test parameters, among other factors.

Fully Automatic Five-part Blood Cell Analyzer Segmentation Breakdown6 items

Application

Hospital

Laboratory

Types

Human Use

Veterinary Use

Regional Insights

Loading chart…

The Fully Automatic Five-part Blood Cell Analyzer market growth is anticipated to vary across regions, with the Asia Pacific region emerging as the largest, accounting for approximately 35% of the global market, driven by factors such as increasing adoption of advanced medical technologies, favorable policies supporting healthcare infrastructure development, and significant investments in research and development. The North America region is expected to be the fastest-growing, driven by rising demographics of aging populations, advancements in infrastructure, and a mature ecosystem that supports innovation.

Key drivers for each region include: for North America, growing demand for accurate diagnostic tools, increased focus on infrastructure development, and a strong ecosystem that supports innovation; for Europe, emphasis on adoption of advanced technologies, stringent policies regulating medical devices, and significant investments in healthcare; for Asia Pacific, large and growing demographics, increasing adoption of digital health technologies, and supportive policies for foreign investments; for Latin America, expanding infrastructure, rising adoption of medical technologies, and growing investments in healthcare; and for Middle East & Africa, increasing adoption of advanced medical technologies, favorable policies for healthcare development, and significant investments in research and development.

Competitive Landscape

The Fully Automatic Five-part Blood Cell Analyzer market is moderately consolidated, with a mix of global players and local/regional companies. The Fully Automatic Five-part Blood Cell Analyzer competitive landscape is driven by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players are focusing on product innovation and strategic partnerships to expand their market share, while local players are leveraging their regional presence and cost advantages to compete.

Companies are adopting various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. To stay competitive, companies need to focus on technology, service model, channel strength, customization, and cost advantages. The following companies are focusing on specific strategic areas:

Sysmex: regional expansion

Beckman Coulter: innovation pipeline

ABBOTT LABORATORIES: premium pricing

Siemens Healthcare Diagnostics Inc: vertical integration

Roche: local manufacturing

HORIBA ABX SAS: OEM tie-ups

Key Fully Automatic Five-part Blood Cell Analyzer Companies18 items

Sysmex

Beckman Coulter

ABBOTT LABORATORIES

Siemens Healthcare Diagnostics Inc

Roche

HORIBA ABX SAS

Boule Diagnostics

Mindray

Biotech

Chengdu Seamaty Technology

Danaher Corporation

Nihon Kohden

Bio-Rad Laboratories

BioSystems

Diatron

Drew Scientific

EKF Diagnostics

Ortho Clinical Diagnostics

Market Ecosystem

The Fully Automatic Five-part Blood Cell Analyzer ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value creation begins with raw material and component suppliers, moves through OEMs and manufacturers, and is ultimately captured by end users. The ecosystem is characterized by a complex interplay of participants, each contributing to the development, production, and distribution of Fully Automatic Five-part Blood Cell Analyzers.

Raw material/component suppliers — providing critical components

OEMs / manufacturers — designing and producing analyzers

Technology providers — developing enabling technologies

System integrators / EPCs — integrating analyzers into laboratory systems

Distributors / channel partners — delivering analyzers to end users

Service providers / after-sales — supporting analyzer maintenance and repair

Regulators/standards bodies — establishing standards and approving analyzers

As value flows through the Fully Automatic Five-part Blood Cell Analyzer ecosystem, control points emerge, influencing adoption and dependency risks. Regulators and standards bodies exert significant influence over the ecosystem, as their approvals and standards can impact the availability and acceptance of analyzers. Meanwhile, switching costs and interoperability requirements can create barriers for end users seeking to transition between different analyzer systems. A thorough value chain analysis is necessary to understand these dynamics and navigate the ecosystem effectively.

Recent Industry Insights

The Fully Automatic Five-part Blood Cell Analyzer industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between leading industry players have enabled the creation of innovative products and solutions. Notable mergers and acquisitions have also led to market consolidation, resulting in enhanced product portfolios and expanded global presence. Furthermore, several companies have launched new products and technologies, focusing on improving accuracy, speed, and usability of blood cell analyzers.

Additionally, regulatory changes have emphasized the need for more stringent quality control and standardization in the industry. Shifts in consumer and enterprise trends have also driven demand for fully automated and compact blood cell analyzers. Funding rounds and expansions have supported the growth of emerging companies, enabling them to invest in research and development and explore new markets.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Fully Automatic Five-part Blood Cell Analyzer market. The market attractiveness is moderate, driven by the increasing demand for accurate and efficient blood cell analysis. The competitive intensity is high, with key players investing in innovation and expansion strategies.

The long-term outlook for the Fully Automatic Five-part Blood Cell Analyzer market outlook is positive, with a growing need for automated solutions in clinical settings. The innovation landscape is characterized by advancements in artificial intelligence and machine learning. However, the demand-supply balance is a key risk factor, as manufacturers struggle to meet the increasing demand for these analyzers.

12 items

1. Executive Summary

2. Fully Automatic Five-part Blood Cell Analyzer Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Fully Automatic Five-part Blood Cell Analyzer Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Fully Automatic Five-part Blood Cell Analyzer Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Fully Automatic Five-part Blood Cell Analyzer Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Fully Automatic Five-part Blood Cell Analyzer Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Fully Automatic Five-part Blood Cell Analyzer Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Fully Automatic Five-part Blood Cell Analyzer Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Fully Automatic Five-part Blood Cell Analyzer Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Fully Automatic Five-part Blood Cell Analyzer Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Fully Automatic Five-part Blood Cell Analyzer Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Fully Automatic Five-part Blood Cell Analyzer Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Fully Automatic Five-part Blood Cell Analyzer Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Fully Automatic Five-part Blood Cell Analyzer Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Fully Automatic Five-part Blood Cell Analyzer Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Fully Automatic Five-part Blood Cell Analyzer Market Competition by Key Manufacturers

9.1. Global Fully Automatic Five-part Blood Cell Analyzer Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Fully Automatic Five-part Blood Cell Analyzer: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Sysmex

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Beckman Coulter

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. ABBOTT LABORATORIES

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Siemens Healthcare Diagnostics Inc

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Roche

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. HORIBA ABX SAS

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Boule Diagnostics

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Mindray

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Biotech

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Chengdu Seamaty Technology

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Danaher Corporation

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Nihon Kohden

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Bio-Rad Laboratories

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. BioSystems

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Diatron

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Drew Scientific

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. EKF Diagnostics

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

10.18. Ortho Clinical Diagnostics

10.18.1. Company Basic Information and Sales Area

10.18.2. Main Business/Business Overview

10.18.3. Product Portfolio

10.18.4. Financial

10.18.5. Recent Industry Insights

10.18.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Fully Automatic Five-part Blood Cell Analyzer Market

Figure 4: Global Fully Automatic Five-part Blood Cell Analyzer Market: Drivers

Figure 5: Global Fully Automatic Five-part Blood Cell Analyzer Market: Challenges

Figure 6: Global Fully Automatic Five-part Blood Cell Analyzer Market: Trends

Figure 7: Global Fully Automatic Five-part Blood Cell Analyzer Market: Opportunity

Figure 8: Global Fully Automatic Five-part Blood Cell Analyzer Market: Restraint

Figure 9: Global Fully Automatic Five-part Blood Cell Analyzer Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Fully Automatic Five-part Blood Cell Analyzer Market Value (USD Million) By Region

Figure 19: Global Fully Automatic Five-part Blood Cell Analyzer Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Fully Automatic Five-part Blood Cell Analyzer Market Value (USD Million) By Region

Figure 27: Global Fully Automatic Five-part Blood Cell Analyzer Market Share (%) By: Regions (2032)

Figure 28: Global Fully Automatic Five-part Blood Cell Analyzer Market Volume (K) By Region

Figure 29: Global Fully Automatic Five-part Blood Cell Analyzer Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Fully Automatic Five-part Blood Cell Analyzer Market Value (USD Million) By Region

Figure 37: Global Fully Automatic Five-part Blood Cell Analyzer Market Share (%) By: Regions (2032)

Figure 38: Global Fully Automatic Five-part Blood Cell Analyzer Market Volume (K) By Region

Figure 39: Global Fully Automatic Five-part Blood Cell Analyzer Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

131 items

Table 1: Market Segmentation Analysis

Table 2: Global Fully Automatic Five-part Blood Cell Analyzer Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Fully Automatic Five-part Blood Cell Analyzer Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Fully Automatic Five-part Blood Cell Analyzer Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Fully Automatic Five-part Blood Cell Analyzer Market Value (USD Million) By Region

Table 14: Global Fully Automatic Five-part Blood Cell Analyzer Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Fully Automatic Five-part Blood Cell Analyzer Market Volume (K) By Region

Table 31: Global Fully Automatic Five-part Blood Cell Analyzer Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Fully Automatic Five-part Blood Cell Analyzer Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Fully Automatic Five-part Blood Cell Analyzer Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Fully Automatic Five-part Blood Cell Analyzer Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Sysmex Basic Information And Sales Area

Table 52: Sysmex. Products Portfolio

Table 53: Beckman Coulter Basic Information And Sales Area

Table 54: Beckman Coulter. Products Portfolio

Table 55: ABBOTT LABORATORIES Basic Information And Sales Area

Table 56: ABBOTT LABORATORIES. Products Portfolio

Table 57: Siemens Healthcare Diagnostics Inc Basic Information And Sales Area

Table 58: Siemens Healthcare Diagnostics Inc. Products Portfolio

Table 59: Roche Basic Information And Sales Area

Table 60: Roche. Products Portfolio

Table 61: HORIBA ABX SAS Basic Information And Sales Area

Table 62: HORIBA ABX SAS. Products Portfolio

Table 63: Boule Diagnostics Basic Information And Sales Area

Table 64: Boule Diagnostics. Products Portfolio

Table 65: Mindray Basic Information And Sales Area

Table 66: Mindray. Products Portfolio

Table 67: Biotech Basic Information And Sales Area

Table 68: Biotech. Products Portfolio

Table 69: Chengdu Seamaty Technology Basic Information And Sales Area

Table 70: Chengdu Seamaty Technology. Products Portfolio

Table 71: Danaher Corporation Basic Information And Sales Area

Table 72: Danaher Corporation. Products Portfolio

Table 73: Nihon Kohden Basic Information And Sales Area

Table 74: Nihon Kohden. Products Portfolio

Table 75: Bio-Rad Laboratories Basic Information And Sales Area

Table 76: Bio-Rad Laboratories. Products Portfolio

Table 77: BioSystems Basic Information And Sales Area

Table 78: BioSystems. Products Portfolio

Table 79: Diatron Basic Information And Sales Area

Table 80: Diatron. Products Portfolio

Table 81: Drew Scientific Basic Information And Sales Area

Table 82: Drew Scientific. Products Portfolio

Table 83: EKF Diagnostics Basic Information And Sales Area

Table 84: EKF Diagnostics. Products Portfolio

Table 85: Ortho Clinical Diagnostics Basic Information And Sales Area

Table 86: Ortho Clinical Diagnostics. Products Portfolio

Table 87: Global Market Value (USD Million) (2025-2032) By Application

Table 88: Global Market Share (%) By Application (2032)

Table 89: Global Market Value (USD Million) (2025-2032) By Types

Table 90: Global Market Share (%) By Types (2032)

Table 91: Global Market Volume (K) (2025-2032) By Application

Table 92: Global Market Share (%) By Application (2032)

Table 93: Global Market Volume (K) (2025-2032) By Types

Table 94: Global Market Share (%) By Types (2032)

Table 95: Global Fully Automatic Five-part Blood Cell Analyzer Market Value (USD Million) By Region

Table 96: Global Fully Automatic Five-part Blood Cell Analyzer Market Share (%) By Region (2025-2032)

Table 97: North America Market Value (USD Million) (2025-2032) By Country

Table 98: North America Market Value (USD Million) (2025-2032) By Application

Table 99: North America Market Value (USD Million) (2025-2032) By Types

Table 100: Europe Market Value (USD Million) (2025-2032) By Country

Table 101: Europe Market Value (USD Million) (2025-2032) By Application

Table 102: Europe Market Value (USD Million) (2025-2032) By Types

Table 103: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 104: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 105: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 106: South America Market Value (USD Million) (2025-2032) By Country

Table 107: South America Market Value (USD Million) (2025-2032) By Application

Table 108: South America Market Value (USD Million) (2025-2032) By Types

Table 109: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 110: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 111: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 112: Global Fully Automatic Five-part Blood Cell Analyzer Market Volume (K) By Region

Table 113: Global Fully Automatic Five-part Blood Cell Analyzer Market Share (%) By Region (2025-2032)

Table 114: North America Market Volume (K) (2025-2032) By Country

Table 115: North America Market Volume (K) (2025-2032) By Application

Table 116: North America Market Volume (K) (2025-2032) By Types

Table 117: Europe Market Volume (K) (2025-2032) By Country

Table 118: Europe Market Volume (K) (2025-2032) By Application

Table 119: Europe Market Volume (K) (2025-2032) By Types

Table 120: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 121: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 122: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 123: South America Market Volume (K) (2025-2032) By Country

Table 124: South America Market Volume (K) (2025-2032) By Application

Table 125: South America Market Volume (K) (2025-2032) By Types

Table 126: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 127: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 128: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 129: Research Programs/Design For This Report

Table 130: Key Data Information From Secondary Sources

Table 131: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Fully Automatic Five-part Blood Cell Analyzer Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.61 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Sysmex; Beckman Coulter; ABBOTT LABORATORIES; Siemens Healthcare Diagnostics Inc; Roche; HORIBA ABX SAS; Boule Diagnostics; Mindray; Biotech; Chengdu Seamaty Technology; Danaher Corporation; Nihon Kohden; Bio-Rad Laboratories; BioSystems; Diatron; Drew Scientific; EKF Diagnostics; Ortho Clinical Diagnostics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options